UNSPSC 51284112: Cefpodoxime

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7R4F94TVGY. European Medicines Agency schedules Cefpodoxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07414MIG. Cefpodoxime generally arises in the molecular formula C15H17N5O6S2.

UNSPSC 51284112 Cefpodoxime is a Commodity code for a specific antibiotic pharmaceutical product, but recent state and local opportunities tagged to this code do not reflect procurement for cefpodoxime itself. Instead, the opportunities show state and local governments buying emergency response pharmaceuticals, medical supplies, and broader multi-source generic pharmaceutical contracts through cooperative and direct purchasing arrangements. The Seminole County, Florida procurement seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually; the City of Tampa is bidding 169 line items of medical and first aid supplies for its fire rescue division; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) is establishing framework contracts for generic multi-source pharmaceuticals and over-the-counter products across multiple state and local jurisdictions. The mismatch between the code name and the actual scope of work suggests this code may be routinely misapplied in state and local procurement systems for pharmaceutical procurements that do not specifically target cefpodoxime.

Activity spans multiple jurisdictions and purchasing models. Issuing bodies include county health departments (Seminole County), municipal fire departments (City of Tampa), state health and human services agencies (Texas HHS Commission), and cooperative purchasing alliances (MMCAP, administered by the Minnesota Department of Administration). The most recent and largest opportunity is MMCAP's RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, establishing two-year contracts with optional extensions across multiple state and local facilities; this procurement emphasizes pricing competitiveness (weighted at 75 percent), compliance with cGMP and DSCSA, and distribution through three authorized wholesalers. The City of Tampa's IFB for medical and first aid supplies, due March 13, 2026, is designated as a sheltered market for certified Small Local Business Enterprises with an estimated contract value of $700,000. The Texas HHS Commission issued an RFI in April 2026 to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and GPO channels. Geographic concentration includes Florida (Seminole County and Tampa), Minnesota (MMCAP), and Texas (HHS Commission), with MMCAP's cooperative model extending across multiple states including Oregon.